Lecheng BD Center Showcases 100+ FDA/CE-Certified Global Healthcare Projects Seeking Chinese Partners

Currently, there is a significant information gap and resource mismatch between the supply and demand sides of the healthcare industry: innovative companies hold core assets but struggle to find ideal partners; meanwhile, demand-side entities lack systematic asset discovery mechanisms and precise value assessment frameworks, leaving them “with capital in hand but unable to locate hidden gems.”

To break this deadlock and effectively bridge the information gap and resource mismatch between investors and fundraisers, the Hainan Lecheng BD Center leverages its extensive overseas resource network, aggregating over 100 high-quality domestic and international projects, with a commitment to providing more advanced solutions for the health of Chinese people.

Most of the innovative healthcare companies behind these overseas projects possess deep technological expertise and strong R&D capabilities in their respective countries or regions. Having already gained prominence in the international market, they are eager to engage in in-depth collaborations with capable Chinese enterprises and institutions to achieve mutual benefits and win-win outcomes.

To facilitate a clearer understanding of the project landscape, we have categorized these overseas projects by domain:

1. Innovative Pharmaceuticals and Biologics:Primarily covers pharmaceutical projects in R&D, manufacturing, innovative drugs and biologics, or those providing innovative therapies, including substances or formulations for the prevention, treatment, or diagnosis of diseases.

More high-quality projects are being updated continuously...

2. Digital Health and AI:It primarily covers healthcare service products that leverage emerging technologies such as the internet and artificial intelligence, or integrate existing technologies, to achieve greater precision and efficiency.

More high-quality projects are being updated continuously...

3. Medical Devices and Intelligent Manufacturing:It primarily covers instruments, equipment, devices, in vitro diagnostic reagents and calibrators, materials, and other similar or related items that are used directly or indirectly on the human body.

More high-quality projects are being updated continuously...

For institutions dedicated to expanding their business footprint in the healthcare sector and seeking high-potential investment opportunities, the 100+ premium overseas projects meticulously curated by the Boao Lecheng Business Development Center represent a strategic opportunity not to be missed.

These projects have undergone rigorous screening and evaluation, demonstrating a high degree of professionalism and innovation while covering multiple frontier directions in the healthcare sector. They not only feature advanced technologies and concepts but also boast broad market prospects and commercial value, offering investors substantial returns.

Interested parties, please scan the QR code below to contact us. Let’s explore the boundless possibilities in the healthcare industry and achieve mutually beneficial growth.

Ms. Wang, VCBeat

To better serve global healthcare enterprises, the Lecheng Pilot Zone has integrated existing resources and leveraged its unique policy advantages to establish the Lecheng BD Center. As a key component of the Hainan Boao Lecheng International Medical Tourism Pilot Zone, the Boao Lecheng BD Center (Lecheng BD Center) is dedicated to promoting the aggregation and development of advanced international medical resources, innovative pharmaceutical and medical device technologies, and the broader health industry. Serving as a vital service platform for the Lecheng Pilot Zone, the BD Center operates with the mission of “Linking Global Resources, Empowering Medical Innovation.” It provides comprehensive business development support to domestic and international pharmaceutical companies, health food manufacturers, manufacturers of foods for special medical purposes (FSMP), medical institutions, research teams, and investors, thereby facilitating Lecheng’s development into a world-class medical tourism destination and a hub for medical innovation.